20
Guided by, K.charhate sir presented by, priyanka R Todkari M-PHARM(Q.A.) 1

Priyanka biotransformation

Embed Size (px)

Citation preview

Page 1: Priyanka  biotransformation

Guided by,K.charhate sir

presented by,priyanka R Todkari

M-PHARM(Q.A.)

1

Page 2: Priyanka  biotransformation

1)INTRODUCTION.

2)FACTORS AFECTING BIOTRANSFORMATION OF DRUG.

- induction of drug metabolising

enzymes

- inhibition of drug metabolising

enzymes.

2

Page 3: Priyanka  biotransformation

Biotansformation is the chemical

modification made by organism on a

chemical compound.

The chemical conversion of one form to

another is called as biotransformation of

drug.

3

Page 4: Priyanka  biotransformation

The alteration of a substance within the

body as by action of enzymes is called

biotransformation.

The term is used synonymously with

metabolism.

4

Page 5: Priyanka  biotransformation

Physicochemical properties of drug.

Biological factors.

chemical factors.

5

Page 6: Priyanka  biotransformation

. 1) molecular size and shape, 2)pKa, 3)acidity/basicity, 4)steric and electronic characterestric of drug. 5)Stereochemical nature of drug.

& 6)Electronic characteristic of a drug

6

Page 7: Priyanka  biotransformation

1) Species differences. 2 ) Strain differences. 3) Sex differences. 4)Age. 5)Diet. .6)Altered Physiochemical Factors- a)Preganacy; b)Hormonal Imbalance; c)disease status. 7)Temporal Factors

a)circardian Rhythm; b) circannual Rhythm.

7

Page 8: Priyanka  biotransformation

1) Induction of drug metabolising

enzymes.

2) Inhibition of drug metabolising

enzymes

8

Page 9: Priyanka  biotransformation

The phenomenon of increased drug

metabolising ability of the enzymes by

several drugs and chemicals is called as

enzyme induction.

The agents which bring about such

effect are known as enzyme inducers.

9

Page 10: Priyanka  biotransformation

a)They are lipophilic compounds.

b) They are sustrate for the inducted

enzyme system.

c) They have long elimination half-lives.

10

Page 11: Priyanka  biotransformation

a)Increase in both liver size and liver blood flow. b)Increase in both total and microsomal

protein content. c) incresed stability of enzymes. d) incresed synthesis of cytochrome P-450. e) decrease degradation of cytochrome

P- 450. f) proliferation smooth endoplasmic reticulum.

11

Page 12: Priyanka  biotransformation

1)Phenobarbitol type inducer.

2)Polycyclic hydrocarbon type inducer.

12

Page 13: Priyanka  biotransformation

a)Decrease in pharmacological activity

of drug.

b)Increased activity where the

matebolitesare active.

c)Altered physiological status due to

enhanced metabolism of endogenous

compounds such as sex harmones.

13

Page 14: Priyanka  biotransformation

14

Inducer Drug with enhanced metabolism.

Barbiturates Coumarins,phenytoin,cortisol,oral

contraceptives.

Alchol Phenobarbital,coumarin

Phenytoin Cortisol,coumarin

Rifampicin Coumarin,tolbutamide

Cigarette Smoke Nicotine,amino azo dyes.

Page 15: Priyanka  biotransformation

A decrease in the metabolisming ability of

an enzyme is called as enzymes

Inhibition.

It may be-

1)Direct Inhibition.

2) Indirect Inhibition.

15

Page 16: Priyanka  biotransformation

It can occurs by one of 3 mechanism.

a) Competitive Inhibition.

b) Non-Competitive Inhibition.

c) Product Inhibition.

16

Page 17: Priyanka  biotransformation

it is brought about by one of the two

mechanisms.

a) Repression.

b) Altered physiology.

17

Page 18: Priyanka  biotransformation

Enzymes Inhibition is more clinically than

enzyme induction.

Some examples of inhibitors and drug

affected by them ,

18

Inhibitors Drugs with Decreased

Metabolism

MAO inhibitors Barbiturates,tyramine

Coumarin Phenytoin

Allupurinol 6-Mercaptopurine

PAS Phenytoin,hexobarbitol.

Page 19: Priyanka  biotransformation

1)D.M.BRAMHANKAR; SUNIL

B.JAISWAL

Page no.140

19

Page 20: Priyanka  biotransformation

20